Advertisement
Screener

Relay Therapeutics, Inc. (RLAY) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

2.0 / 5 stars · 20/51 Roast Me

Relay Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

Relay Therapeutics, Inc. (RLAY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $30.14 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-25.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2021-03-25

  • Relay Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $30.14, a 802.40% increase from fiscal 2019.
  • Relay Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2019 was $3.34.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month
2020-12-31$30.14
10-K · filed 2021-03-25
2019-12-31$3.34
10-K · filed 2021-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)United States$4.897B-6.51
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
CRISPR Therapeutics AG (CRSP)$5.390B-11.68
Greenland Mines Ltd (GRML)United States$2.362B
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12